Efficacy of selenium supplementation for mild-to-moderate Graves ’ ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial
DiscussionThe SeGOSS study will evaluate the therapeutic potential of selenium for mild-to-moderate GO in a selenium-sufficient area and provide support in tailoring better treatment for GO.Trial registrationKCT0004040. Retrospectively registered on 5 June 2019.https://cris.nih.go.kr/cris/search/detailSearch.do/14160. (Source: Trials)
Source: Trials - April 14, 2023 Category: Research Source Type: clinical trials
Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer
Conditions: Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Niraparib; Other: Questionnaire Administration; Dietary Supplement: Selenium Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2023 Category: Research Source Type: clinical trials
Effects on the Scalp Lipids and TEWL of a 1% Selenium Disulfide and 1% Salicylic Acid Antidandruff Shampoo on Dandruff Scalp
Condition: Dandruff Intervention: Other: 1% Selenium Disulfide (SeS2)/1% salicylic acid-based shampoo Sponsor: L'Oreal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2022 Category: Research Source Type: clinical trials
